![Editors in Conversation artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts113/v4/b8/68/dd/b868dd9f-5a51-91c9-fb51-f8d1567e8465/mza_5151066038574592298.jpg/100x100bb.jpg)
Therapeutic approaches for COVID-19: Myths and facts (AAC Journal)
Editors in Conversation
English - August 04, 2020 19:40 - 31 minutes - 21.5 MB - ★★★★ - 10 ratingsLife Sciences Science Health & Fitness Medicine asm for fox interviews jeff magazine microbe microbiology news science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: MMP #17: How bacteria can change graphene to propel rotors.
Next Episode: Diagnostic Tests for COVID-19 (JCM ed.)
Objectives:
• Discuss the therapeutic options currently being used for COVID-19
• Evaluate some clinical data supporting the use of these drugs
• Comment on clinical trials and enrollment
Participants:
• Andre Kalil, Professor, University of Nebraska Medical Center, Omaha, NB, USA. Lead Investigator, NIH Clinical Trial for COVId-19
• Miguel A. Martinez, Editor AAC. Professor, AIDS Research Institute-IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Visit https://aac.asm.org/ to browse issues and/or submit a manuscript.